Meet industry experts & discuss the latest advances in drug development at SMi's Pain Therapeutics 2012

Top Quote Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK. End Quote
  • (1888PressRelease) March 30, 2012 - Pain is the most common reason patients seek medical care, as it affects the quality of life many people experience and has significant sensory and emotional components. Whilst advances have been made in pain management, few significant ones have occurred, making it harder in recent years to get analgesics to market.

    In the current economic climate, this makes it even more imperative for companies to improve their R&D methods so that drugs being put forward for clinical trials have the best chance of success.

    Hear key presentations from industry-leading experts:
    Kevin Lee, Head of Epigenetics Discovery Unit, Epinova (GlaxoSmithKline)
    Chas Bountra, Professor of Translational Medicine, Head, Structural Genomics Centre Oxford University
    Jonathan Stewart, Disease Area Head, Neuroscience, Immunology and Pain, Bristol-Myers Squibb
    Philip Kym, Associate Director II Pain Discovery Research, Abbott
    Mark Bowlby, Neurophysiology and Pain Lead, Merck
    Dave Shelton, Senior Director, Pfizer Global Research & Development

    Key reasons to attend:
    Evaluate recent advances in experimental pain models and translational techniques
    Discuss the current topics in CNS clinical trials
    Develop strategies to improve the chance of success for your candidate drugs
    Discover how epigenetics can help in the elucidation of new targets
    Learn about the current targets in pain drug development and their potential for new therapies
    Network with key industry associates and solution providers to share valuable experiences

    Visit for more information or to register your place. Alternatively, contact Murad Al-Abdullah at Tel: +44 (0)207 827 6115 or Email: mal-abdullah ( @ ) smi-online dot co dot uk

    About SMi Group
    Pain Therapeutics 2012 is just one of the many conferences that are a part of the SMi Group portfolio. The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi's highly targeted conferences, workshops and publications. For more information, visit

    For further information, contact:
    Murad Al-Abdullah
    Tel: +44 (0)207 827 6115
    Email: mal-abdullah ( @ ) smi-online dot

  • FB Icon Twitter Icon In-Icon
Contact Information